The discovery of LY6E as a potential target for cancer intervention has driven considerable effort. Several therapeutic candidates are currently developed with the goal of directly inhibiting LY6E's role and eliciting an antitumor effect in those suffering with multiple cancers . Hurdles remain in optimizing protein targeting and mitigating potenti